News Release
Home
News Release
- 2026.03.13 lR Information
- Notice Concerning the Convocation of an Extraordinary General Shareholders’ Meeting Regarding Share Consolidation, Abolition of Provisions on Share Units, and Partial Amendment of the Articles of Incorporation
- 2026.03.13 lR Information
- Announcement of Cancellation of Treasury Shares
- 2026.02.20 lR Information
- Notice Regarding Results of Tender Offer for Shares, Etc. of Hisamitsu Pharmaceutical Co., Inc. by TAIYO KOSAN CO., INC. and Change in Parent Company, the Largest Shareholder that is a Major Shareholder, and Major Shareholder
- 2026.02.13 lR Information
- Notice Regarding Setting of Record Date for Convening Extraordinary General Meeting of Shareholders
- 2026.02.03 lR Information
- (Amendment) Notice Regarding Commencement of Tender Offer by TAIYO KOSAN CO.,INC. for Share Certificates, Etc. of Hisamitsu Pharmaceutical Co., Inc. (Securities Code: 4530)
- 2026.01.07 lR Information
- Announcement of Implementation of MBO and Recommendation for Tendering Shares
- 2026.01.07 lR Information
- Notice Regarding Commencement of Tender Offer by TAIYO KOSAN CO.,INC. for Share Certificates, Etc. of Hisamitsu Pharmaceutical Co., Inc. (Securities Code: 4530)
- 2026.01.06 lR Information
- FY02/2026 Q3 Results Earnings Release Presentation
- 2026.01.06 lR Information
- Announcement on Revision of the Dividend Forecast for the Fiscal Year Ending February 28, 2026 (No Dividend)
- 2026.01.06 lR Information
- Announcement on Withdrawal of the Earnings Forecast for the Fiscal Year Ending February 28, 2026
